Insider Transactions in Q1 2023 at Tarsus Pharmaceuticals, Inc. (TARS)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 23
2023
|
Leonard M. Greenstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
346
-1.08%
|
$4,152
$12.15 P/Share
|
|
Mar 23
2023
|
Jose M. Trevejo CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
465
-7.08%
|
$5,580
$12.15 P/Share
|
|
Mar 23
2023
|
Seshadri Neervannan Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
390
-0.71%
|
$4,680
$12.15 P/Share
|
|
Mar 23
2023
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Direct |
737
-7.9%
|
$8,844
$12.15 P/Share
|
|
Mar 23
2023
|
Bryan Wahl General Counsel |
SELL
Open market or private sale
|
Direct |
371
-2.21%
|
$4,452
$12.15 P/Share
|
|
Mar 23
2023
|
Aziz Mottiwala Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
372
-0.7%
|
$4,464
$12.15 P/Share
|
|
Mar 23
2023
|
Dianne C. Whitfield Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
345
-2.98%
|
$4,140
$12.15 P/Share
|
|
Mar 22
2023
|
Leonard M. Greenstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
332
-1.02%
|
$3,984
$12.64 P/Share
|
|
Mar 22
2023
|
Jose M. Trevejo CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
529
-7.45%
|
$6,348
$12.64 P/Share
|
|
Mar 22
2023
|
Seshadri Neervannan Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
379
-0.68%
|
$4,548
$12.64 P/Share
|
|
Mar 22
2023
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Direct |
709
-7.06%
|
$8,508
$12.64 P/Share
|
|
Mar 22
2023
|
Bryan Wahl General Counsel |
SELL
Open market or private sale
|
Direct |
357
-2.08%
|
$4,284
$12.64 P/Share
|
|
Mar 22
2023
|
Aziz Mottiwala Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
357
-0.67%
|
$4,284
$12.64 P/Share
|
|
Mar 22
2023
|
Dianne C. Whitfield Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
333
-2.8%
|
$3,996
$12.64 P/Share
|
|
Mar 21
2023
|
Leonard M. Greenstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
326
-0.99%
|
$3,912
$12.89 P/Share
|
|
Mar 21
2023
|
Jose M. Trevejo CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
519
-6.81%
|
$6,228
$12.89 P/Share
|
|
Mar 21
2023
|
Seshadri Neervannan Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
372
-0.67%
|
$4,464
$12.89 P/Share
|
|
Mar 21
2023
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Direct |
679
-6.33%
|
$8,148
$12.89 P/Share
|
|
Mar 21
2023
|
Bryan Wahl General Counsel |
SELL
Open market or private sale
|
Direct |
350
-2.0%
|
$4,200
$12.89 P/Share
|
|
Mar 21
2023
|
Aziz Mottiwala Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
349
-0.65%
|
$4,188
$12.89 P/Share
|
|
Mar 21
2023
|
Dianne C. Whitfield Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
326
-2.67%
|
$3,912
$12.89 P/Share
|
|
Mar 20
2023
|
Bryan Wahl General Counsel |
SELL
Open market or private sale
|
Direct |
357
-2.0%
|
$4,284
$12.61 P/Share
|
|
Mar 20
2023
|
Dianne C. Whitfield Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
333
-2.65%
|
$3,996
$12.61 P/Share
|
|
Mar 20
2023
|
Jose M. Trevejo CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
530
-6.5%
|
$6,360
$12.61 P/Share
|
|
Mar 20
2023
|
Seshadri Neervannan Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
380
-0.68%
|
$4,560
$12.61 P/Share
|
|
Mar 20
2023
|
Mark J. Holdbrook V.P., Clinical Affairs |
SELL
Open market or private sale
|
Direct |
198
-5.84%
|
$2,376
$12.61 P/Share
|
|
Mar 20
2023
|
Aziz Mottiwala Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
358
-0.66%
|
$4,296
$12.61 P/Share
|
|
Mar 20
2023
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Direct |
741
-6.46%
|
$8,892
$12.61 P/Share
|
|
Mar 20
2023
|
Leonard M. Greenstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
333
-1.01%
|
$3,996
$12.61 P/Share
|
|
Mar 17
2023
|
Bryan Wahl General Counsel |
SELL
Open market or private sale
|
Direct |
339
-1.87%
|
$4,407
$13.28 P/Share
|
|
Mar 17
2023
|
Dianne C. Whitfield Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
316
-2.45%
|
$4,108
$13.28 P/Share
|
|
Mar 17
2023
|
Jose M. Trevejo CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
504
-5.82%
|
$6,552
$13.28 P/Share
|
|
Mar 17
2023
|
Seshadri Neervannan Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
360
-0.64%
|
$4,680
$13.28 P/Share
|
|
Mar 17
2023
|
Mark J. Holdbrook V.P., Clinical Affairs |
SELL
Open market or private sale
|
Direct |
188
-5.26%
|
$2,444
$13.28 P/Share
|
|
Mar 17
2023
|
Aziz Mottiwala Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
339
-0.62%
|
$4,407
$13.28 P/Share
|
|
Mar 17
2023
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Direct |
795
-6.49%
|
$10,335
$13.28 P/Share
|
|
Mar 17
2023
|
Leonard M. Greenstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
316
-0.95%
|
$4,108
$13.28 P/Share
|
|
Mar 16
2023
|
Dianne C. Whitfield Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
313
-2.37%
|
$4,069
$13.43 P/Share
|
|
Mar 16
2023
|
Bryan Wahl General Counsel |
SELL
Open market or private sale
|
Direct |
337
-1.82%
|
$4,381
$13.43 P/Share
|
|
Mar 16
2023
|
Mark J. Holdbrook V.P., Clinical Affairs |
SELL
Open market or private sale
|
Direct |
187
-4.97%
|
$2,431
$13.43 P/Share
|
|
Mar 16
2023
|
Seshadri Neervannan Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
357
-0.63%
|
$4,641
$13.43 P/Share
|
|
Mar 16
2023
|
Aziz Mottiwala Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
336
-0.61%
|
$4,368
$13.43 P/Share
|
|
Mar 16
2023
|
Jose M. Trevejo CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
499
-5.45%
|
$6,487
$13.43 P/Share
|
|
Mar 16
2023
|
Leonard M. Greenstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,313
-6.91%
|
$69,069
$13.44 P/Share
|
|
Mar 16
2023
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Direct |
791
-6.06%
|
$10,283
$13.43 P/Share
|
|
Mar 15
2023
|
William J Phd Link Director |
BUY
Other acquisition or disposition
|
Indirect |
52,194
+43.18%
|
-
|
|
Mar 15
2023
|
William J Phd Link Director |
SELL
Other acquisition or disposition
|
Indirect |
215,575
-50.0%
|
-
|
|
Mar 15
2023
|
Dianne C. Whitfield Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,462
+25.28%
|
-
|
|
Mar 15
2023
|
Bryan Wahl General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
4,790
+20.56%
|
-
|
|
Mar 15
2023
|
Mark J. Holdbrook V.P., Clinical Affairs |
BUY
Exercise of conversion of derivative security
|
Direct |
2,653
+41.34%
|
-
|